RUNX3 and non-small cell lung carcinoma: Another important clinical study demonstrated hypermethylation of RUNX family transcription factor 3 (RUNX3) in the serum samples of gastric, non-small cell lung cancer (NSCLC), and pancreatic, liver, and colorectal cancers, whereas no methylation was detected in healthy samples [24].